Favorable Press Coverage Somewhat Unlikely to Affect Blackrock Health Sciences Trust (BME) Stock Price

Media coverage about Blackrock Health Sciences Trust (NYSE:BME) has been trending positive recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Blackrock Health Sciences Trust earned a media sentiment score of 0.44 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.3657579515458 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Shares of Blackrock Health Sciences Trust opened at $36.39 on Wednesday, Marketbeat.com reports. Blackrock Health Sciences Trust has a twelve month low of $32.81 and a twelve month high of $38.00.

The company also recently declared a monthly dividend, which will be paid on Thursday, May 31st. Stockholders of record on Tuesday, May 15th will be paid a $0.20 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 6.60%. The ex-dividend date is Monday, May 14th.

About Blackrock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Insider Buying and Selling by Quarter for Blackrock Health Sciences Trust (NYSE:BME)

Receive News & Ratings for Blackrock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackrock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply